ECSP941068A - Derivados de la cefalosporina - Google Patents

Derivados de la cefalosporina

Info

Publication number
ECSP941068A
ECSP941068A EC1994001068A ECSP941068A ECSP941068A EC SP941068 A ECSP941068 A EC SP941068A EC 1994001068 A EC1994001068 A EC 1994001068A EC SP941068 A ECSP941068 A EC SP941068A EC SP941068 A ECSP941068 A EC SP941068A
Authority
EC
Ecuador
Prior art keywords
lower alkyl
hydrogen
cycloalkyl
alkenyl
aniloxy
Prior art date
Application number
EC1994001068A
Other languages
English (en)
Inventor
Peter Angehrn
Chung-Chen Wei
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ECSP941068A publication Critical patent/ECSP941068A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

De la fórmula general: en donde R1 es un grupo acilo derivado de un ácido carboxílico; R2 es hidrógeno, hidroxilo, alquilo-Qm inferior, cicloalquilo, alcoxilo inferior, alquenilo inferior, alquenilo inferior, cicloalquenilo, alquinilo inferior, aralquilo-Qm, anilo-Qm, aniloxilo, aralcoxilo o un anillo heterocíclico, siendo el alquilo inferior, cicloalquilo, alcoxilo inferior, alquenilo inferior, cicloalquenilo, alquinilo inferior, aralquilo, anilo, aniloxilo, aralcoxilo y el anillo heterocíclico, sin substituir o substituidos con por lo menos un grupo seleccionado entre carboxilo, amino, nitro, ciano, alquilo inferior, alcoxilo inferior, hidroxilo, halógeno, -CONR4R5, -N (R5) COOR9, R5 CO-, R5 OCO- o R5 COO-, en donde R4 es hidrógeno, alquilo inferior o cicloalquilo; R5 es hidrógeno o alquilo inferior; R9 es hidrógeno, alquilo inferior, alquenilo inferior o un grupo protector de ácido carboxílico.; Q es - CO- ó - SO2; M es O ó 1 N es O, 1 ó 2 así como ésteres fácilmente hidrolizables de las mismas sales farmacéuticamente aceptables de dichos compuestos e hidratos de los compuestos de fórmula I y de sus ésteres y sales.
EC1994001068A 1993-04-16 1994-04-15 Derivados de la cefalosporina ECSP941068A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4868893A 1993-04-16 1993-04-16

Publications (1)

Publication Number Publication Date
ECSP941068A true ECSP941068A (es) 1994-11-16

Family

ID=21955891

Family Applications (1)

Application Number Title Priority Date Filing Date
EC1994001068A ECSP941068A (es) 1993-04-16 1994-04-15 Derivados de la cefalosporina

Country Status (7)

Country Link
US (1) US5523400A (es)
KR (1) KR100309516B1 (es)
EC (1) ECSP941068A (es)
RO (1) RO114965B1 (es)
TN (1) TNSN94030A1 (es)
UY (1) UY23757A1 (es)
YU (1) YU19494A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199700859T1 (xx) * 1995-02-27 1998-02-21 F. Hoffmann-La Roche Ag 3-Pirolidiliden-2-on-sefalosporin t�revleri.
US5804577A (en) * 1995-09-12 1998-09-08 Hoffmann-La Roche Inc. Cephalosporin derivatives
US5811419A (en) * 1996-01-16 1998-09-22 Hoffmann-La Roche Inc. Isooxacephem-derivatives
US5883247A (en) * 1996-06-10 1999-03-16 Hoffmann-La Roche Inc. Preparation of cephem and isooxacephem derivatives
TW446707B (en) * 1996-10-22 2001-07-21 Hoffmann La Roche Cephalosporin pyridinium derivatives
ATE354577T1 (de) 1996-11-06 2007-03-15 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporin-derivate
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents
US6114541A (en) * 1997-03-10 2000-09-05 Hoffmann-La Roche Inc. Method for the preparation of α-Bromo-Lactam derivatives
CA2335288A1 (en) * 1998-06-22 1999-12-29 F. Hoffmann-La Roche Ag Propenyl cephalosporin derivatives
ATE370146T1 (de) 1999-07-05 2007-09-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von cephalosporin- derivaten
US7662955B2 (en) * 2003-03-20 2010-02-16 Orchid Chemicals And Pharmaceuticals Ltd. Process for the preparation of cefoxitin
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20090214600A1 (en) * 2008-02-25 2009-08-27 Debrouse Daniel R Methods and compositions for gastric resistant oral formulations for intestinal delivery
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN105418641B (zh) * 2015-12-30 2018-08-10 广东金城金素制药有限公司 一种原研制品质头孢曲松钠及其药物制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496562A (en) * 1977-03-14 1985-01-29 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted-3-cephem-4-carboxylic acid esters
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
US5171854A (en) * 1987-05-26 1992-12-15 Bayer Aktiengesellschaft Substituted vinylcephalosporins
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina

Also Published As

Publication number Publication date
YU19494A (sh) 1998-05-15
RO114965B1 (ro) 1999-09-30
US5523400A (en) 1996-06-04
TNSN94030A1 (fr) 1995-04-25
KR100309516B1 (ko) 2006-05-25
UY23757A1 (es) 1994-10-03

Similar Documents

Publication Publication Date Title
ES2185634T3 (es) Derivados de cefalosporina.
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
ES2055056T3 (es) Derivados de pirimidopirimidina.
AR011913A1 (es) Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
YU19494A (sh) Derivati cefalosporina
DK351788A (da) Tetrahydroisoquinolin-2-ylderivater af carboxylsyrer som thromboxan-a2-antagonister
AR012603A1 (es) Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis
CA2168563A1 (en) Benzopyrans and Pharmaceutical Compositions Containing Them
DK448684A (da) Alkyldiaminderivater og deres anvendelse som laegemidler
ES8604601A1 (es) Procedimiento de preparar derivados de penicilina
DK432086A (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
NO940498D0 (no) Nye cykliske ureaforbindelser som er nyttige som antiarytmiske og antifibrillatoriske midler
AR005454A1 (es) Derivados de isooxacefem, su uso, procedimiento para su preparacion y preparaciones farmaceuticas que contienen a dichos derivados.
CO4900072A1 (es) Derivados de 1-carba-(detia)-cefalosporina
ES2045514T3 (es) Utilizacion de derivados del cromano para el tratamiento de los estados depresivos.
ECSP972262A (es) Derivados de 1-carba (detia)-cefalosporina
AR006997A1 (es) Proceso para la preparacion de derivados ureicos e intermediarios de sintesis
HU9503718D0 (en) Serotoninergic abeo-ergoline derivatives
MX9706187A (es) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas.
CO4910143A1 (es) Derivados de cefalosporin piridinio
ATE26275T1 (de) Acridanon-derivate.
FI944967L (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi
ECSP972291A (es) Derivados de cepalosporin piridinio (caso rn 4410/256)
GT199400068A (es) Derivados de cefalosporina
ECSP972131A (es) B - lactamas